Jasti Property and Equity Holdings Private Limited, acting as the sole trustee of the Jasti Family Trust, has disclosed its acquisition of additional shares in Cohance Lifesciences Limited. This transaction, conducted via inter-se transfer through block deals, resulted in a 1.33% increase in voting rights for the acquirer. Following the acquisition, the total holding of Jasti Property and Equity Holdings and its associated persons in Cohance Lifesciences stands at 6.36% of the total voting capital.
Significant Share Acquisition
Jasti Property and Equity Holdings Private Limited, in its capacity as the sole trustee of the Jasti Family Trust, has made a substantial acquisition of shares in Cohance Lifesciences Limited. The disclosure, filed in accordance with SEBI regulations, details the transfer of voting rights and equity. The transactions occurred between November 09, 2026 and November 11, 2026.
Transaction Details
The acquisition involved 51,00,000 shares carrying voting rights, representing 1.33% of the total share capital and 1.26% of the total diluted share capital of Cohance Lifesciences. This was executed through inter-se transfer via block deals. Prior to this acquisition, the total holding of the acquirer and persons acting in concert was 6.36% (2,43,26,009 shares). Following the transaction, the consolidated holding of Jasti Property and Equity Holdings Private Limited (on behalf of the Trust) and its associated persons (PAC) amounts to 6.36% (2,43,26,009 shares) of the total equity shares.
Holding Structure Post-Acquisition
After the acquisition, the details of the holding are as follows:
- Jasti Property and Equity Holdings Private Limited (on behalf of the Trust): 45,16,009 shares (1.18% voting rights, 1.11% diluted share capital)
- Jasub Property Holdings LLP (PAC): 1,98,00,000 shares (5.18% voting rights, 4.88% diluted share capital)
- Other PACs (Mrs. Venkata Subbamma Jasti, Mrs. Sudharani Jasti, Mr. Venkateswarlu Jasti) hold negligible percentages.
The total equity share capital of Cohance Lifesciences Limited before and after the acquisition remains 38,25,97,330 equity shares. The total diluted share capital post-acquisition stands at 40,59,80,385 shares.
Source: BSE
